Johnson Chemical Pharmaceutical Works Co Ltd (4747) - Total Liabilities
Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) has total liabilities worth NT$279.70 Million TWD (≈ $8.81 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Johnson Chemical Pharmaceutical Works Co (4747) net asset momentum to track the company's year-over-year net asset growth rate.
Johnson Chemical Pharmaceutical Works Co Ltd - Total Liabilities Trend (2009–2024)
This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 4747 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Total Liabilities
The table below lists competitors of Johnson Chemical Pharmaceutical Works Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alliance Aviation Services Ltd
AU:AQZ
|
Australia | AU$718.22 Million |
|
American Vanguard Corporation
NYSE:AVD
|
USA | $475.62 Million |
|
Goodfellow Inc.
TO:GDL
|
Canada | CA$103.35 Million |
|
Flag Ship Acquisition Corp. Unit
NASDAQ:FSHPU
|
USA | $2.93 Million |
|
Genohco Inc.
KQ:361390
|
Korea | ₩42.57 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.03 Billion |
|
Coeptis Therapeutics Inc
NASDAQ:COEP
|
USA | $3.26 Million |
|
Nano X Imaging Ltd
NASDAQ:NNOX
|
USA | $19.46 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Johnson Chemical Pharmaceutical Works Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Johnson Chemical Pharmaceutical Works Co market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Johnson Chemical Pharmaceutical Works Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2024)
The table below shows the annual total liabilities of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$261.36 Million ≈ $8.23 Million |
-18.58% |
| 2023-12-31 | NT$320.99 Million ≈ $10.11 Million |
+91.56% |
| 2022-12-31 | NT$167.56 Million ≈ $5.28 Million |
-6.34% |
| 2021-12-31 | NT$178.91 Million ≈ $5.64 Million |
-25.55% |
| 2020-12-31 | NT$240.33 Million ≈ $7.57 Million |
+131.54% |
| 2019-12-31 | NT$103.79 Million ≈ $3.27 Million |
+3.49% |
| 2018-12-31 | NT$100.29 Million ≈ $3.16 Million |
+4.87% |
| 2017-12-31 | NT$95.64 Million ≈ $3.01 Million |
-22.30% |
| 2016-12-31 | NT$123.09 Million ≈ $3.88 Million |
+28.26% |
| 2015-12-31 | NT$95.97 Million ≈ $3.02 Million |
-17.97% |
| 2014-12-31 | NT$117.00 Million ≈ $3.69 Million |
+16.92% |
| 2013-12-31 | NT$100.06 Million ≈ $3.15 Million |
+47.30% |
| 2012-12-31 | NT$67.93 Million ≈ $2.14 Million |
-23.07% |
| 2011-12-31 | NT$88.30 Million ≈ $2.78 Million |
+22.53% |
| 2010-12-31 | NT$72.06 Million ≈ $2.27 Million |
+25.94% |
| 2009-12-31 | NT$57.22 Million ≈ $1.80 Million |
-- |
About Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more